跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XiangDan
首页
药物
XiangDan
XiangDan
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Xiangdan injection process
申请人: SHANGHAI LIUHETANG BIOLOGICAL TECH XIANGCHENG PHARMACEUTICAL CO LTD
优先权: 2023
CN
Xiangdan injection production system
申请人: BICON PHARMACEUTICAL JIANGSU CO LTD
优先权: 2012
CN
Xiangdan injection and preparation method thereof
申请人: YUN LONG
优先权: 2023
CN
Nano medicine 'Xiangdan' and its preparing process
申请人: YANG MENGJUN
优先权: 2001
CN
Xiangdan injection as well as preparation device and preparation process thereof
申请人: SHANGHAI LIUHETANG BIOLOGICAL TECH XIANGCHENG PHARMACEUTICAL CO LTD
优先权: 2025
CN
Xiangdan medicament injection preparation containing polyethylene glycol 12-hydroxystearate and preparation method thereof
申请人: SICHUAN SUNNYHOPE PHARMACEUTICAL CO LTD
优先权: 2010
CN
Prescription and use of salviae miltiorrhizae or lignum santali and salviae miltiorrhizae injection plus soluble intravenous infusion preparation
申请人: LI RONGYAO
优先权: 2003
CN
Pharmaceutical composition for treating acute kidney failure
申请人: UNIV ZHEJIANG
优先权: 2005
CN
药物
反馈